Press Releases


Latest News


Adamas Announces New Employment Inducement Grant
May 6, 2016 | General Releases

Adamas Announces Positive Top-line Results from its Phase 3 EASE LID 3 Trial of ADS-5102 for the Treatment of Levodopa-induced Dyskinesia (LID) in Patients with Parkinson's Disease
Apr 28, 2016 | General Releases

Adamas to Host Conference Call and Webcast to Provide Company Update
Apr 28, 2016 | General Releases

Adamas Presents Positive Findings From the Phase 3 EASE LID Clinical Trial of ADS-5102 for the Treatment of Levodopa-induced Dyskinesia (LID) Associated with Parkinson's Disease at the American Academy of Neurology Annual Meeting
Apr 20, 2016 | General Releases

Adamas Announces Data Update at the 68th American Academy of Neurology Annual Meeting
Apr 14, 2016 | General Releases

Adamas Reports Fourth Quarter and Full Year 2015 Financial Results
Feb 23, 2016 | Financial Releases

Adamas Pharmaceuticals to Present at Two Upcoming Healthcare Conferences
Feb 22, 2016 | General Releases

Adamas Pharmaceuticals Provides Review of 2015 and Projected Future Milestones
Jan 12, 2016 | General Releases

Adamas Announces Pricing of Public Offering of Common Stock
Jan 7, 2016 | General Releases

Adamas Announces Proposed Public Offering of Common Stock
Jan 5, 2016 | General Releases

Pages:  1 2 3 4 5 6 7 8 9 10 11